SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:2047 2919 OR L773:2047 2927 "

Sökning: L773:2047 2919 OR L773:2047 2927

  • Resultat 1-10 av 55
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Isaksson, Sigrid, et al. (författare)
  • Inhibin B concentration is predictive for long-term azoospermia in men treated for testicular cancer.
  • 2014
  • Ingår i: Andrology. - : Wiley. - 2047-2927 .- 2047-2919. ; 2:2, s. 252-258
  • Tidskriftsartikel (refereegranskat)abstract
    • Azoospermia is a serious potential side effect following treatment for testicular cancer (TC). Our purpose was to examine possible predictors of long-term azoospermia in TC survivors. Ejaculates and blood samples were obtained from 217 patients at post-orchidectomy but before further treatment (T0 ) and/or at one or more of the time points 6, 12, 24, 36-60 months after treatment (T6 , T12 , T24 , T36-60 ). All patients delivered ejaculates at T36-60 , of which 117 also had confirmed presence of spermatozoa in the ejaculate at T0 , enabling longitudinal analyses. Types of therapy, cryptorchidism and Inhibin B before and after treatment were evaluated in relation to risk of azoospermia at T36 . Inhibin B levels at T6 , T12 and T24 were predictors of azoospermia at T36 with cut-off levels at 49.7, 55.9 and 97.8 ng/L respectively (sensitivity 100%, specificity 57-78%). The frequency of azoospermia in all patients at T36-60 was 7.8% (95% CI 4.9-12%). As compared to surveillance patients, only those receiving >4 cycles of chemotherapy or ≥4 cycles of chemotherapy + radiotherapy (RT) had increased risk of long-term azoospermia (63% vs. 4.4% in the surveillance group; p = 0.0018). In conclusion, all patients with sperm production at post-orchidectomy but before further treatment and Inhibin B >56 ng/L 12 months after treatment had sperm production 3 years post-treatment. Eight per cent of TC survivors had azoospermia 3-5 years post-treatment, with highest risk in those receiving >4 cycles of chemotherapy or ≥4 cycles of chemotherapy in combination with RT.
  •  
2.
  • Oleszczuk, Krzysztof, et al. (författare)
  • Prevalence of high DNA fragmentation index in male partners of unexplained infertile couples.
  • 2013
  • Ingår i: Andrology. - : Wiley. - 2047-2927 .- 2047-2919. ; 1:3, s. 357-360
  • Tidskriftsartikel (refereegranskat)abstract
    • The sperm chromatin structure assay (SCSA) parameter DNA fragmentation Index (DFI) is a valuable tool for prediction of fertility in vivo. Clinical data show that a DFI above 30% is associated with very low chance for achieving pregnancy by natural conception or by insemination. Already when DFI is above 20% the chance of natural pregnancy is reduced, this despite normal conventional semen parameters. The aim of the present study was to investigate the prevalence of high DFI in male partners of unexplained infertile couples to further identification of male factors contributing to subfertility. Among 212 consecutive men under infertility investigation, 122 cases with the diagnosis 'unexplained infertility' were identified. For all but three, SCSA data were available. The percentage of couples with diagnosis 'unexplained infertility' in which the male partner has DFI >20% or DFI >30% was calculated. In the group diagnosed with 'unexplained infertility' 17.7% of the men (95% CI 10.8-24.5) presented with 20 ≤DFI <30 and 8.4% (95% CI 3.40-13.4) had DFI ≥30%. A significant part of men diagnosed as unexplained infertile according to traditional diagnostic methods has remarkably high degrees of fragmented sperm DNA. Apart from adding to our understanding of biology of infertility our finding has clinical implications. Couples in which the DFI of the male partner is high can avoid prolonged attempts to become spontaneously pregnant or referral for intrauterine insemination, both having low chances of leading to conception.
  •  
3.
  • Kaspersen, M. D., et al. (författare)
  • No increased sperm DNA fragmentation index in semen containing human papillomavirus or herpesvirus
  • 2013
  • Ingår i: Andrology. - : Wiley. - 2047-2927 .- 2047-2919. ; 1:3, s. 361-364
  • Tidskriftsartikel (refereegranskat)abstract
    • It remains unknown whether human papillomaviruses (HPVs) or human herpesviruses (HHVs) in semen affect sperm DNA integrity. We investigated whether the presence of these viruses in semen was associated with an elevated sperm DNA fragmentation index. Semen from 76 sperm donors was examined by a PCR-based hybridization array that identifies all HHVs and 35 of the most common HPVs. Sperm DNA integrity was determined by the sperm chromatin structure assay. HPVs or HHVs, or both, were found in 57% of semen samples; however, sperm DNA fragmentation index was not increased in semen containing these viruses.
  •  
4.
  •  
5.
  • Anand-Ivell, Ravinder, et al. (författare)
  • Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort
  • 2022
  • Ingår i: Andrology. - : Wiley. - 2047-2919 .- 2047-2927. ; 10:7, s. 1328-1338
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Aging in men is accompanied by a broad range of symptoms, including sexual dysfunction, cognitive and musculoskeletal decline, obesity, type 2 diabetes, cardiovascular disease and hypertension, organ degeneration/failure, and increasing neoplasia, some of which are associated with declining levels of Leydig cell-produced testosterone. High natural biological variance, together with multiple factors that can modulate circulating testosterone concentration, may influence its interpretation and clinical implications. Insulin-like peptide 3 is a biomarker of Leydig cell function that might provide complementary information on testicular health and its downstream outcomes. Objectives: To characterize insulin-like peptide 3 as a biomarker to assess gonadal status in aging men. Methods and materials: A large European multicenter (European Male Aging Study) cohort of community-dwelling men was analyzed to determine how insulin-like peptide 3 relates to a range of hormonal, anthropometric, and lifestyle parameters. Results and discussion: Insulin-like peptide 3 declines cross-sectionally and longitudinally within individuals at approximately 15% per decade from age 40 years, unlike testosterone (1.9% per decade), which is partly compensated by increasing pituitary luteinizing hormone production. Importantly, lower insulin-like peptide 3 in younger men appears to persist with aging. Multiple regression analysis shows that, unlike testosterone, insulin-like peptide 3 is negatively dependent on luteinizing hormone and sex hormone-binding globulin and positively dependent on follicle-stimulating hormone, suggesting a different mechanism of gonadotropic regulation. Circulating insulin-like peptide 3 is negatively associated with increased body mass index or waist circumference and with smoking, and unlike testosterone, it is not affected by weight loss in obese individuals. Geographic variation in mean insulin-like peptide 3 within Europe appears to be largely explained by differences in these parameters. The results allowed the establishment of a European-wide reference range for insulin-like peptide 3 (95% confidence interval) adjusted for increasing age. Conclusion: Insulin-like peptide 3 is a constitutive biomarker of Leydig cell functional capacity and is a robust, reliably measurable peptide not subject to gonadotropin-dependent short-term regulation and within-individual variation in testosterone.
  •  
6.
  •  
7.
  •  
8.
  • Arver, S, et al. (författare)
  • In Memoriam: Rune Eliasson MD, PhD
  • 2020
  • Ingår i: ANDROLOGY. - : Wiley. - 2047-2919 .- 2047-2927. ; 8:3, s. 530-531
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
  •  
9.
  • Axelsson, Jonatan, et al. (författare)
  • Exposure to polycyclic aromatic hydrocarbons and nicotine, and associations with sperm DNA fragmentation
  • 2022
  • Ingår i: Andrology. - : Wiley. - 2047-2919 .- 2047-2927. ; 10:4, s. 740-748
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Tobacco smoking has been reported to cause DNA fragmentation and has been suggested to cause mutations in spermatozoa. These effects have been ascribed to the action of polycyclic aromatic hydrocarbons (PAH) present in the smoke. Simultaneously, DNA fragmentation has been associated with mutagenesis. Objective: The aim of this study was to investigate whether levels of urinary biomarkers of PAH and nicotine exposure were associated with sperm DNA fragmentation. Methods: In the urine of 381 men recruited from two cohorts of young men (17–21 years old) from the general Swedish population, the PAH metabolites 1-hydroxypyrene and 2-hydroxyphenanthrene, as well as the nicotine metabolite cotinine, were measured. The sperm DNA fragmentation index (DFI) was analysed using the sperm chromatin structure assay. Associations between the DFI, and PAH metabolite levels as continuous variables as well as in quartiles, were studied by general linear models adjusted for abstinence time. A similar analysis was carried out for cotinine levels, according to which the men were categorised as “non-smoking” (n = 216) and “smoking” (n = 165). Results: No association was found between levels of any of the three biomarkers and DFI, either as a continuous variable (p = 0.87–0.99), or when comparing the lowest and the highest quartiles (p = 0.11–0.61). The same was true for comparison of men categorised as non-smoking or smoking (DFI 11.1% vs. 11.8%, p = 0.31). Discussion: We found no evidence of PAH or nicotine exposure to be associated with DFI, which does not exclude that these exposures may have other effects on sperm DNA. Conclusion: In these young men, levels of biomarkers of nicotine and PAH exposure were not associated with DFI.
  •  
10.
  • Barranco, I., et al. (författare)
  • The activity of paraoxonase type 1 (PON-1) in boar seminal plasma and its relationship with sperm quality, functionality, and in vivo fertility
  • 2015
  • Ingår i: Andrology. - : American Society of Andrology. - 2047-2919 .- 2047-2927. ; 3:2, s. 315-320
  • Tidskriftsartikel (refereegranskat)abstract
    • Paraoxonase 1 (PON-1) is a hydrolytic enzyme present in body fluids, capable of protecting cells against oxidative stress. The hypothesis was hereby to test that PON-1, present in seminal plasma (SP), acts protecting boar spermatozoa when showing a reasonable high activity in the ejaculate. SP-PON-1 activity differed (pless than0.001) among boars (from 0.10 to 0.29IU/mL). Intra-boar variability was also observed (pless than0.05), but only in two of the 15 boars. SP-PON-1 activity differed among ejaculate portions, showing the spermatozoa-peak portion of spermatozoa-rich ejaculate fraction the highest levels (0.35 +/- 0.03IU/mL, ranging from 0.12 to 0.69) and the post-sperm ejaculate fraction the lowest levels (0.12 +/- 0.01IU/mL, ranging from 0.03 to 0.21). SP-PON-1 activity was positively correlated with the percentage of spermatozoa with rapid and progressive movement (pless than0.01) and negatively correlated with the generation of intracellular reactive oxygen species (pless than0.01) in semen samples after 72h of liquid storage. SP-PON-1 activity was highest (pless than0.01) in boars with highest farrowing rates. In conclusion, SP-PON-1 activity differed among boars and ejaculate fractions/portions. SP-PON-1 activity was positively correlated with sperm quality and functionality of liquid-stored semen samples and it evidenced a positive association with in vivo fertility.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 55
Typ av publikation
tidskriftsartikel (52)
forskningsöversikt (3)
Typ av innehåll
refereegranskat (50)
övrigt vetenskapligt/konstnärligt (5)
Författare/redaktör
Giwercman, Aleksande ... (14)
Giwercman, A (6)
Rodriguez-Martinez, ... (5)
Arver, S (5)
Bjorndahl, L (4)
Almqvist, C (3)
visa fler...
Nordenskjold, A (3)
Lundholm, C (3)
Bungum, Mona (3)
Axelsson, Jonatan (3)
Leijonhufvud, I. (3)
Hofmann, Marie Claud ... (3)
Levy, M. (2)
Rohrmann, S. (2)
Toppari, J (2)
Sud, A (2)
Bhasin, S (2)
Kvist, U (2)
Huhtaniemi, Ilpo (2)
Lindh, Christian (2)
Kibel, AS (2)
Turnbull, C (2)
Ståhl, Olof (2)
Elenkov, Angel (2)
Wiklund, F (2)
Huddart, RA (2)
Cohn-Cedermark, G (2)
Lindh, Christian H. (2)
Jahnukainen, K (2)
Frisen, L. (2)
Bonde, Jens Peter (2)
Toft, Gunnar (2)
Maggi, Mario (2)
Van Hemelrijck, M (2)
Kanarek, N (2)
Huang, G. (2)
Reid, A (2)
Hougaard, Karin Søri ... (2)
Hærvig, Katia Keglbe ... (2)
Tøttenborg, Sandra S ... (2)
Ramlau-Hansen, Cecil ... (2)
Giwercman, Yvonne Lu ... (2)
Salonia, Andrea (2)
Houlston, RS (2)
Storer, TW (2)
Litchfield, K (2)
Esteves, SC (2)
Isaksson, Sigrid (2)
Bobjer, J. (2)
Phillips, L. (2)
visa färre...
Lärosäte
Lunds universitet (23)
Karolinska Institutet (23)
Linköpings universitet (6)
Göteborgs universitet (2)
Uppsala universitet (2)
Örebro universitet (2)
visa fler...
Malmö universitet (2)
Stockholms universitet (1)
Linnéuniversitetet (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (55)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (36)
Naturvetenskap (1)
Lantbruksvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy